Global and pancreas-specific overexpression of let-7 results in impaired glucose tolerance, while let-7 inhibition leads to an insulin-sensitized state that can resist high fat diet-induced diabetes, and it is sufficient in this case to treat glucose tolerance impairment [51,52]. The gene discussed is INS; the disease is Impaired glucose tolerance.